Cargando…

Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer

PURPOSE: N6-methyladenosine (m6A) is reported to play a critical role in cancer through various mechanisms. We aimed to construct and validate an m6A RNA methylation regulators-based prognostic signature for Esophageal cancer (ESCA). MATERIALS AND METHODS: The RNA sequencing transcriptome data of 13...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Li-chao, Pan, Jing-xin, Pan, Hong-da
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352013/ https://www.ncbi.nlm.nih.gov/pubmed/32753956 http://dx.doi.org/10.2147/CMAR.S254870

Ejemplares similares

Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma
por: Pan, Jingxin, et al.
Publicado: (2020)

Construction and validation of m(6)A RNA methylation regulators associated prognostic model for gastrointestinal cancer
por: Miao, Yandong, et al.
Publicado: (2022)

Construction and Validation of Novel Diagnostic and Prognostic DNA Methylation Signatures for Hepatocellular Carcinoma
por: Li, Ran, et al.
Publicado: (2020)

Construction of m6A-Related lncRNA Prognostic Signature Model and Immunomodulatory Effect in Glioblastoma Multiforme
por: Xie, Pan, et al.
Publicado: (2022)

Construction and validation of a m6A RNA methylation and ferroptosis-related prognostic model for pancreatic cancer by integrated bioinformatics analysis
por: Wu, Tong, et al.
Publicado: (2022)

Identification of the Signature Associated With m(6)A RNA Methylation Regulators and m(6)A-Related Genes and Construction of the Risk Score for Prognostication in Early-Stage Lung Adenocarcinoma
por: Guo, Bingzhou, et al.
Publicado: (2021)

Gene Signatures and Prognostic Values of m6A RNA Methylation Regulators in Ovarian Cancer
por: Han, Xiao, et al.
Publicado: (2020)

Four m6A RNA Methylation Gene Signatures and Their Prognostic Values in Lung Adenocarcinoma
por: Wang, Yuzhu, et al.
Publicado: (2022)

Development and validation of m6A RNA methylation regulators-based signature in lung adenocarcinoma
por: Guo, Wei, et al.
Publicado: (2021)

Construction and validation of an m6A RNA methylation regulator prognostic model for early-stage clear cell renal cell carcinoma
por: Wang, Zhan, et al.
Publicado: (2022)

Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma
por: Shen, Chengquan, et al.
Publicado: (2021)

Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma
por: Zhang, Xi, et al.
Publicado: (2021)

Construction of miRNA-mRNA Regulatory Network and Prognostic Signature in Endometrial Cancer
por: Sun, Rui, et al.
Publicado: (2021)

Prognostic Value of an m6A RNA Methylation Regulator-Based Signature in Patients with Hepatocellular Carcinoma
por: Wu, Xiaomin, et al.
Publicado: (2020)

Construction and validation of an N6-methyladenosine-associated prognostic signature in hepatocellular carcinoma
por: Zhu, Peng, et al.
Publicado: (2021)

The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma
por: Liu, Tao, et al.
Publicado: (2019)

The prognostic values of m6A RNA methylation regulators in uveal melanoma
por: Tang, Jing, et al.
Publicado: (2020)

Constructing and validating of m6a-related genes prognostic signature for stomach adenocarcinoma and immune infiltration: Potential biomarkers for predicting the overall survival
por: Yang, Jing, et al.
Publicado: (2022)

Development and validation of an m6A RNA methylation regulator-based signature for the prediction of prognosis and immunotherapy in cutaneous melanoma
por: Li, Tingting, et al.
Publicado: (2023)

Development and validation of a m(6)A -regulated prognostic signature in lung adenocarcinoma
por: Chen, Yaxin, et al.
Publicado: (2022)

Construction of a four-mRNA prognostic signature with its ceRNA network in CESC
por: Li, Lang, et al.
Publicado: (2022)

Identification and validation of m(6)A RNA methylation regulators with clinical prognostic value in Papillary thyroid cancer
por: Wang, Xinyi, et al.
Publicado: (2020)

m(6)A mRNA methylation regulates CTNNB1 to promote the proliferation of hepatoblastoma
por: Liu, Li, et al.
Publicado: (2019)

Development and validation of an autophagy-related prognostic signature in esophageal cancer
por: Du, Hailei, et al.
Publicado: (2021)

The functions and prognostic values of m6A RNA methylation regulators in thyroid carcinoma
por: Yu, Zhi-Hao, et al.
Publicado: (2021)

Prognostic value of a five-lncRNA signature in esophageal squamous cell carcinoma
por: zhang, Lan, et al.
Publicado: (2020)

Construction and validation of an eight-gene signature with great prognostic value in bladder cancer
por: Yan, Xin, et al.
Publicado: (2020)

Development and Validation of a 6-miRNA Prognostic Signature in Spinal Chordoma
por: Huang, Wei, et al.
Publicado: (2020)

Construction and validation of an immunity-related prognostic signature for breast cancer
por: Zhu, Tao, et al.
Publicado: (2020)

Construction and validation of a novel ferroptosis-related prognostic signature for lung adenocarcinoma
por: Yang, Li, et al.
Publicado: (2023)

Correction to: m6A mRNA methylation regulates CTNNB1 to promote the proliferation of hepatoblastoma
por: Liu, Li, et al.
Publicado: (2020)

Corrigendum: Development and validation of a m(6)A -regulated prognostic signature in lung adenocarcinoma
por: Chen, Yaxin, et al.
Publicado: (2023)

Identification and validation of the N6-methyladenosine RNA methylation regulator ZC3H13 as a novel prognostic marker and potential target for hepatocellular carcinoma
por: Wu, Shuang, et al.
Publicado: (2022)

Identification of serum prognostic marker miRNAs and construction of microRNA-mRNA networks of esophageal cancer
por: Jiang, Yue, et al.
Publicado: (2021)

Prognostic Implication of the m(6)A RNA Methylation Regulators in Rectal Cancer
por: Chen, Yajie, et al.
Publicado: (2021)

Construction and Validation of an Autophagy-Related Prognostic Signature and a Nomogram for Bladder Cancer
por: Yan, Xin, et al.
Publicado: (2021)

Integrating 13 Microarrays to Construct a 6 RNA-binding proteins Prognostic Signature for Gastric Cancer patients
por: Zhou, Liqiang, et al.
Publicado: (2021)

Identification of an eight-m6A RNA methylation regulator prognostic signature of uterine corpus endometrial carcinoma based on bioinformatics analysis
por: Miao, Chenyun, et al.
Publicado: (2021)

Identification of a Two-m6A RNA Methylation Regulator Risk Signature as an Independent Prognostic Biomarker in Papillary Renal Cell Carcinoma by Bioinformatic Analysis
por: Yang, Feilong, et al.
Publicado: (2021)

Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma
por: Sun, Zhuolun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gvahpc0mok02cs9qsjr9l38gdi